Major Healthcare Stock Positions of Caxton Associates

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Wall St. Watchdog reveals information regarding Caxton Associates’ top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 100 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $217.659 million.

  • Vivus Inc. (NASDAQ:VVUS): On 06/30/2011 reported holding 3,939,626 shares with a market value of $32,068,557. This comprised 1.24% of the total portfolio. On 09/30/2011 reported holding 3,939,626 shares with a market value of $31,792,781. This comprised 1.57% of the total portfolio. The net change in shares for this position over the two quarters is 0. About Company: VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. The company markets a treatment for erectile dysfunction, and has drugs for obesity and erectile dysfunction in late-stage clinical trials.
  • Biogen Idec Inc. (NASDAQ:BIIB): On 06/30/2011 reported holding 120,983 shares with a market value of $12,935,502. This comprised 0.5% of the total portfolio. On 09/30/2011 reported holding 189,750 shares with a market value of $17,675,213. This comprised 0.87% of the total portfolio. The net change in shares for this position over the two quarters is 68,767. About Company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Allergan Inc. (NYSE:AGN): On 06/30/2011 reported holding 127,868 shares with a market value of $10,645,011. This comprised 0.41% of the total portfolio. On 09/30/2011 reported holding 158,821 shares with a market value of $13,083,674. This comprised 0.65% of the total portfolio. The net change in shares for this position over the two quarters is 30,953. About Company: Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
  • Gilead Sciences Inc. (NASDAQ:GILD): On 06/30/2011 reported holding 183,151 shares with a market value of $7,584,283. This comprised 0.29% of the total portfolio. On 09/30/2011 reported holding 145,991 shares with a market value of $5,664,451. This comprised 0.28% of the total portfolio. The net change in shares for this position over the two quarters is -37,160. About Company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
  • Aetna Inc. (NYSE:AET): On 06/30/2011 reported holding 334,794 shares with a market value of $14,761,068. This comprised 0.57% of the total portfolio. On 09/30/2011 reported holding 154,993 shares with a market value of $5,632,446. This comprised 0.28% of the total portfolio. The net change in shares for this position over the two quarters is -179,801. About Company: Aetna Inc. is a diversified health care benefits company that provides healthcare and related benefits, serving health care members, dental members, and group insurance customers. The Company offers medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.
  • Intuitive Surgical Inc. (NASDAQ:ISRG): On 06/30/2011 reported holding 1,616 shares with a market value of $601,330. This comprised 0.02% of the total portfolio. On 09/30/2011 reported holding 14,751 shares with a market value of $5,373,494. This comprised 0.27% of the total portfolio. The net change in shares for this position over the two quarters is 13,135. About Company: Intuitive Surgical, Inc. design, manufactures and markets surgical systems. The Company’s surgical system controls Intuitive Surgical endoscopic instruments, including rigid endoscopes, blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pickups, needle holders, endoscopic retractors, electrocautery, ultrasonic cutters, and accessories during surgical procedures.
  • Medicis Pharmaceutical Corp. (NYSE:MRX): On 06/30/2011 reported holding 12,355 shares with a market value of $471,590. This comprised 0.02% of the total portfolio. On 09/30/2011 reported holding 141,551 shares with a market value of $5,163,780. This comprised 0.26% of the total portfolio. The net change in shares for this position over the two quarters is 129,196. About Company: Medicis Pharmaceutical Corporation provides pharmaceuticals focusing on the treatment of dermatological, pediatric, and podiatric conditions, as well as aesthetics medicine. The Company has branded prescription products in therapeutic categories such as acne, asthma, eczema, fungal infections, hyperpigmentation, photoaging, psoriasis, and rosacea.
  • Forest Laboratories Inc. (NYSE:FRX): On 06/30/2011 reported holding 0 shares. On 09/30/2011 reported holding 166,500 shares with a market value of $5,126,535. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is 166,500. About Company: Forest Laboratories, Inc. develops, manufactures, and sells both branded and generic forms of ethical products which require a physician’s prescription. The Company also manufactures non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses. Forest’s products are marketed in the United States and eastern Europe.
  • Questcor Pharmaceuticals Inc (NASDAQ:QCOR): On 06/30/2011 reported holding 183,907 shares with a market value of $0. This comprised 0% of the total portfolio. On 09/30/2011 reported holding 180,459 shares with a market value of $4,919,312. This comprised 0.24% of the total portfolio. The net change in shares for this position over the two quarters is -3,448. About Company: Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company’s primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.
  • Wellcare Health Plans Inc. (NYSE:WCG): On 06/30/2011 reported holding 118,190 shares with a market value of $6,076,148. This comprised 0.23% of the total portfolio. On 09/30/2011 reported holding 127,630 shares with a market value of $4,847,387. This comprised 0.24% of the total portfolio. The net change in shares for this position over the two quarters is 9,440. About Company: WellCare Health Plans Inc provides managed care services targeted exclusively to government-sponsored healthcare programs. The Company operates health plans in multiple states.

(Note: Data regarding Caxton Associates’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More Articles About:
Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business